The Baltic Times

Nuvaxovid vaccine to be available for Latvian residents next week

  • 2022-02-22
  • LETA/TBT Staff

RIGA - Next week, Latvian residents will be able to choose also Nuvaxovid vaccine produced by Czech company Novavax which was registered in the EU in December 2021, LETA learned from the Vaccination Project Department.

Information about the medical establishments where Nuvaxovid vaccine is available will be published on the Health Ministry's internet website starting from February 28.

Nuvaxovid if the fifth vaccine registered in the EU.

 

Please enter your username and password.

 Forgot your password?
 

Subscribe!

A subscription to The Baltic Times is a cost-effective way of staying in touch with the latest Baltic news and views enabling you full access from anywhere with an Internet connection. Subscribe Now!

About The Baltic Times

The Baltic Times is an independent monthly newspaper that covers latest political, economic, business, and cultural events in Estonia, Latvia and Lithuania. Born of a merger between The Baltic Independent and The Baltic Observer in 1996, The Baltic Times continues to bring objective, comprehensive, and timely information to those with an interest in this rapidly developing area of the Baltic Sea region. Read more... Our news analysis and commentaries provide readers with insight essential to understanding the three Baltic countries and their neighbors.

Publisher: Gene Zolotarev
Editor in chief: Linas Jegelevicius

Contact Us

Editorial: editor@baltictimes.com
Subscription: subscription@baltictimes.com
Advertising: adv@baltictimes.com

Stay Connected

2024 © The Baltic Times /Cookies Policy